Overview
About Biolidics
Board of Directors
Key Executive Officer
Oncology
Oncology
Products
Resources And Publications
Request for a Quotation
Investor Relations
IR Home
Reports
Announcements
Stock Information
Email Alerts
Contact
Corporate Office
Careers Opportunity
Personal Data Policy
Whistle Blowing Policy
News
Back
31 Aug 2020
Proposed Issuance Of Up To 2,723,500 Shares - Allotment And Issuance Of 1,168,000 Shares
Attachment 1
Locate Us
Contact Us
Enquiry Form
Whatsapp Us